<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Hospira, Inc., et al.; Withdrawal of Approval of 21 Abbreviated New Drug Applications</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Hospira, Inc., et al.; Withdrawal of Approval of 21 Abbreviated New Drug Applications</h1>
    <p class="timestamp">Published: 2022-05-20 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is withdrawing approval of 21 abbreviated new drug applications (ANDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-10924</p>
    <p><strong>Publication Date:</strong> 2022-05-20</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/05/20/2022-10924/hospira-inc-et-al-withdrawal-of-approval-of-21-abbreviated-new-drug-applications">https://www.federalregister.gov/documents/2022/05/20/2022-10924/hospira-inc-et-al-withdrawal-of-approval-of-21-abbreviated-new-drug-applications</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-10924</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
